In the notice published in the New Zealand Gazette, 23 October 2008, No. 162, page 4246, the following product entries are to be deleted from Full Consent, section 20 and to be placed under Provisional Consent, section 23 with the heading as follows:
Provisional Consent to the Distribution of a Medicine
Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the medicine set out in the Scheduled hereto:
Schedule
Product: Levothyroxine
Active Ingredient: Levothyroxine sodium, anhydrous 50µg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir New Zealand Limited t/a Goldshield Healthcare (New Zealand)
Manufacturer: Custom Pharmaceuticals Limited (UK), Brighton, East Sussex, United Kingdom
Product: Levothyroxine
Active Ingredient: Levothyroxine sodium, anhydrous 100µg
Dosage Form: Tablet
New Zealand Sponsor: Boucher & Muir New Zealand Limited t/a Goldshield Healthcare (New Zealand)
Manufacturer: Custom Pharmaceuticals Limited (UK), Brighton, East Sussex, United Kingdom
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 100µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 112µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 125µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 137µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 150µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 175µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 200µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 25µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 300µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 50µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 75µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 88µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories Inc, Puerto Rico, United States of America
Note: This consent is valid for two years from the date of publication of this notice.
Dated this 31st day of October 2008.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).